Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection
Dan-Yu Lin, Yu Gu, Donglin Zeng, Holly E. Janes, Peter B. Gilbert
doi: https://doi.org/10.1101/2021.04.16.21255614
Dan-Yu Lin
1Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA
Yu Gu
1Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA
Donglin Zeng
1Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA
Holly E. Janes
2Vaccine and Infectious Disease Division, Fred Hutch, Seattle, Washington, USA
Peter B. Gilbert
2Vaccine and Infectious Disease Division, Fred Hutch, Seattle, Washington, USA
Posted April 17, 2021.
Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection
Dan-Yu Lin, Yu Gu, Donglin Zeng, Holly E. Janes, Peter B. Gilbert
medRxiv 2021.04.16.21255614; doi: https://doi.org/10.1101/2021.04.16.21255614
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (191)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)